Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Dividend Update
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals board has recommended a dividend of Rs. 4 per equity share (200% on face value of Rs. 2) for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the company's 47th Annual General Meeting. The company has not yet announced the record date or tentative payment date, stating these will be communicated separately. This appears to be a standard dividend recommendation consistent with the company's practice.
For shareholders, this represents a positive income event if approved at the AGM. The 200% payout signals the company generated sufficient profits. However, the exact dividend yield depends on the prevailing stock price, and investors should monitor for the record date announcement to be eligible for the dividend.